Solvay Share: Nearly +4% Over a Week, Chemical Company Adds 1.5% This Morning
The Belgian chemical company is advancing mid-morning in a well-oriented Paris market. The share is recovering after several weeks of consolidation, without however confirming a reversal beyond its longer-term moving averages.
A gain of 1.69% bringing the price to the level of its 20-day moving average
Solvay shares are trading at €25.22 following a 1.69% increase compared to the previous day (€24.80). The share is at the level of its 20-day MA at €25.12, with a difference of 0.40%. This rebound occurs while the SBF 120 advances 0.98% and the CAC 40 by 0.94%. Over the week, the stock gains 3.96%, but remains down 4.25% over one month.
The RSI at 42 remains neutral and reflects a still modest rebound, far from a trend reversal. The 50-day MA (€25.72) is 1.94% above the price and the 200-day MA (€26.42) at 4.54%, which leaves the share below its medium-term benchmarks. The brief from October 2 on Solvay share's rebound already described a similar surge, in a technical configuration described as deteriorated.
Between support at €24.26 and resistance at €26.34, a still broad corridor
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The price is moving between support at €24.26 and resistance at €26.34, representing a corridor of approximately 8% wide. The first level is 3.8% below the current price, the second is 4.4% above. The MACD remains negative (-0.2388), but its histogram at -0.0126 is close to zero, a sign of a gap narrowing with the signal line.
The oil context remains tense, with Brent at $102.51 per barrel, declining 1.70% in the session after a rise of around 6% over nine sessions. Going forward, the 50-day MA at €25.72 is the closest level for the share to reclaim.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
